Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
HCPCS Code

HCPCS code Q4169 – MicroMatrix and AmnioArmor billing guide


Code Definition

Q4169 is the HCPCS Level II code for Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure).

It reports Artacent Wound, an amniotic membrane skin substitute, at one unit per square centimeter of product applied to a qualifying chronic wound. Since January 1, 2026, Medicare pays skin substitutes without a biologics license as incident-to supplies, at one flat rate per square centimeter. Coverage still turns on wound type, failed conservative care, and your MAC's current policy.

Level
Level II
Category
Q4101-Q4440 Skin substitutes and biologicals
Code range
Q4169 Artacent wound, per square centimeter (add-on)
Billable
No
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

HCPCS Code Q4169 reports Artacent Wound, an amniotic skin substitute billed per square centimeter as an add-on to the application procedure.

Medicare coverage needs a qualifying chronic wound, documented failure of conservative care, and a claim that meets your MAC’s current skin substitute policy.

Since January 1, 2026, CMS pays non-BLA skin substitutes as incident-to supplies at one flat rate per square centimeter, not quarterly ASP.

Report one unit per square centimeter of product applied, never bill discarded product, and leave the JW and JZ modifiers off the line.

Pabau, our practice management software, records wound measurements and notes in the patient record and submits claims through Claim.MD.

HCPCS Code Q4169: definition and covered product

HCPCS Code Q4169 reports Artacent Wound, an amniotic membrane skin substitute applied to chronic wounds. Its official descriptor reads “Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure),” per the AAPC code listing for Q4169.

The code covers one product only. AmnioArmor has its own code, Q4188, while AmnioBand bills under Q4168 and Cygnus under Q4170. Bill Q4169 only when the application note names Artacent Wound.

Q4169 sits in the skin substitutes and biologicals range, Q4101 through Q4440, which CMS publishes and maintains through quarterly HCPCS updates. As an add-on code, it is always reported with a skin substitute application code from the 15271-15278 range. A trunk, arm, or leg wound starts with CPT 15271 for the first 25 sq cm.

FieldDetail
CodeQ4169
Code systemHCPCS Level II (temporary Q-codes)
Covered productArtacent Wound
Product typeAmniotic membrane skin substitute
Unit1 unit = 1 sq cm of product
ReportingAdd-on, listed with the primary application procedure
Code rangeQ4101-Q4440 (skin substitutes and biologicals)
Adjacent codesQ4168 (AmnioBand, 1 mg), Q4170 (Cygnus, per sq cm)

Medicare coverage criteria for HCPCS Code Q4169

Medicare covers Q4169 when the claim meets the skin substitute policy of your Medicare Administrative Contractor (MAC). In December 2025, CMS announced that the MACs were withdrawing the new skin substitute LCDs scheduled for January 1, 2026. Some MACs still apply older skin substitute LCDs, while others review each claim for medical necessity.

The qualifying wound types accepted across most policies include diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, and non-healing surgical wounds. Beyond wound type, the claim must also show that standard conservative care failed before the skin substitute was applied.

  • Wound type: Diabetic foot ulcer, venous leg ulcer, pressure ulcer, or non-healing surgical wound
  • Duration: Wound present for at least four weeks under most skin substitute policies, with documented treatment during that period
  • Conservative care failure: Evidence that standard wound care (moist wound therapy, compression, offloading) was attempted and failed before the skin substitute was used
  • Provider credentials: Application performed by a licensed provider whose scope covers wound care procedures
  • Frequency limits: Check your MAC’s current policy for per-wound and per-episode application limits
  • Product match: The product applied must be Artacent Wound. AmnioArmor, AmnioBand, and Cygnus each bill under their own Q-code

Many Medicare Advantage plans add prior authorization requirements on top of traditional Medicare rules. Some commercial payers classify amniotic membrane products as experimental or investigational and deny them regardless of clinical justification. Verify payer policy before applying the product.

Pro Tip

Pull your MAC’s current skin substitute policy before the first Q4169 claim of the year. CMS withdrew the LCDs planned for 2026, so the rules your MAC applies now may differ from last year’s. Keep a saved copy in the wound care protocol file.

ICD-10 diagnosis codes accepted with Q4169

The ICD-10-CM diagnosis codes on the claim must fall within the wound categories your MAC’s policy covers. Using a diagnosis code outside the covered list is one of the most common and easiest-to-prevent denial reasons for HCPCS Code Q4169. For a diabetic foot ulcer, pair E11.621 with an L97 code that names the ulcer’s site and severity.

ICD-10-CM codeDescriptionNotes
E11.621Type 2 DM with foot ulcerMost common DFU code paired with Q4169
E11.622Type 2 DM with other skin ulcerUse with L97 series for wound site
I83.001-I83.029Varicose veins with ulcer (VLU series)Specify laterality and site
L89.xxxPressure ulcer (site and stage)Stage 3 or higher is typically required. Check your MAC’s policy.
L97.xxxNon-pressure chronic skin ulcerOften paired with diabetic or vascular codes
T81.30xA-T81.33xADisruption of wound, various typesUse for non-healing surgical wounds; initial encounter codes only

Always cross-reference the specific diagnosis codes against your MAC’s current covered-diagnosis list. Some MACs publish a companion article with the exact ICD-10-CM codes that satisfy medical necessity for skin substitutes. A code outside that list makes the claim likely to be denied, even when it is clinically accurate. An appeal must then show the policy criteria were met.

Unit calculation and reporting for Q4169

Q4169 is reported in square centimeters of Artacent Wound. One unit equals one square centimeter of product, per the code descriptor. Measure the wound at application so the record supports the size of product you applied. The flow below shows where each check sits on the claim line.

Five-step flow for building a HCPCS Q4169 claim line
Each unit is one square centimeter of Artacent Wound applied, and the CY 2026 national rate of $127.14 prices it before locality adjustment. Figures from the HCPCS descriptor and the November 2025 Federal Register correction.

How to calculate units

  1. Measure wound length and width at the longest perpendicular dimensions, in centimeters
  2. Select the product size that covers the wound, and record the size applied
  3. Report one unit per square centimeter of Artacent Wound applied to the wound
  4. Document the wound measurements and product size in the medical record, because auditors compare them against the billed units
  5. If you treat multiple wounds in the same encounter, record each wound’s measurements, product size, and wound-site ICD-10 code separately

Common error: billing discarded product. Medicare does not pay for discarded amounts of an incident-to supply. CMS limits the JW and JZ modifiers to separately payable drugs and biologicals, so leave them off Q4169. Follow your MAC’s instructions for documenting any discarded amount.

Place of service and 2026 reimbursement for Q4169

For 2026, CMS changed how Medicare pays for most skin substitutes. The CY 2026 Physician Fee Schedule final rule reclassified products not licensed under a biologics license application (BLA) as incident-to supplies. Medicare now pays them at a single national rate per square centimeter, set for the year rather than updated quarterly from ASP data.

A November 2025 correction notice in the Federal Register set that CY 2026 rate at $127.14 per square centimeter. Artacent Wound, like most amniotic allografts, is not a BLA-licensed biologic, so it falls under this policy. Confirm the product’s category with your MAC before you bill.

POS codeSettingPayment basis (2026)Key billing note
POS 11Office (non-facility)Flat per-sq-cm incident-to supply rateThe practice buys the product and bills Q4169 with the application procedure
POS 22Outpatient hospitalCY 2026 OPPS skin substitute policy, which largely mirrors the office rateThe hospital bills the product on its facility claim, not the physician
POS 24Ambulatory surgical centerCY 2026 ASC payment rulesCheck the ASC payment addenda for Q4169 before scheduling

Quarterly ASP files no longer set the Q4169 rate in 2026. Check your MAC’s fee schedule for the locality-adjusted amount before you quote a figure to a patient or a manager.

Prior authorization requirements for Q4169

Traditional Medicare does not require national prior authorization for Q4169. Rules can still differ by MAC and by program, so check your MAC’s current policy before assuming no prior authorization is needed.

Medicare Advantage plans often require prior authorization for skin substitute codes, and many apply their own coverage policies. Confirm the plan’s requirements and turnaround time before you schedule the application.

Commercial insurers vary widely. Some classify amniotic membrane wound products as investigational, which makes approval unlikely regardless of documentation quality. Verify the specific plan’s coverage policy before applying the product.

Documentation that supports a Q4169 claim

Auditors deny many Q4169 claims because the chart cannot show what was applied or why. The medical record must support both medical necessity (why the product was needed) and the claim specifics (which product, what size, applied to which wound).

Pabau’s patient records keep wound measurements and visit notes together, so each application sits alongside the history behind it. Its digital intake forms capture the patient’s history before the visit, which helps show the conservative care tried before the skin substitute.

Detailed patient records in Pabau
Pabau’s patient record keeps each wound measurement and treatment note on one timeline, so a Q4169 claim has its supporting documentation in one place.
  • Wound measurements: Length, width, and depth at every visit, recorded in centimeters
  • Wound photography: Date-stamped photos at application and follow-up visits, where your MAC’s policy asks for them
  • Wound history: Date of wound onset and evidence the wound has been present for the policy’s minimum duration
  • Conservative treatment record: Dates, type, and outcome of prior wound care (moist dressings, compression therapy, offloading devices)
  • Product application note: Product name (Artacent Wound), lot number, size applied, any product discarded, and wound site
  • Provider credentials: Application performed and documented by a provider with wound care scope of practice
  • Visit frequency justification: Clinical rationale for the application frequency, particularly if approaching policy limits

Pro Tip

Create a Q4169 documentation checklist and attach it to every wound care encounter template. Before submitting the claim, run through each checklist item. A single missing element, such as an unsigned application note or an undated wound photo, is enough to trigger a denial or a post-payment recoupment.

Adjacent skin substitute codes: Q4168, Q4170, and Q4188

Neighboring Q-codes each name a single product, so the code follows the product named on the application note. Billing the wrong one is a coding error and an overpayment risk.

CodeProductUnitKey distinction
Q4168AmnioBand1 mgBilled by weight, not by area
Q4169Artacent WoundPer sq cm, add-onThe code this guide covers
Q4170CygnusPer sq cm, add-onA different product with its own code
Q4188AmnioArmorPer sq cm, add-onAmnioArmor never bills under Q4169

The usual error is coding by product type rather than product name. If your practice stocks several amniotic products, check the product name on the application note before you assign the HCPCS code. For a broader crosswalk of related skin substitute codes, the AAPC HCPCS code lookup and CrossCoder both allow side-by-side descriptor comparison.

Common Q4169 denial reasons and how to resolve them

Most Q4169 denials fall into a predictable set of categories. The table below maps each denial type to its most common CARC code. It also lists the corrective action with the best chance of recovery. Our guide to medical billing denial codes explains each CARC and RARC in more detail.

Claims screen in Pabau
Pabau’s claims screen tracks each submitted claim and its status, so a denied Q4169 line is easy to find and correct.
Denial reasonCommon CARCCorrective action
Missing wound documentationCARC 16 / 50Appeal with complete wound measurement record and photos
ICD-10 not on the covered listCARC 50 / 167Review the MAC policy, correct the diagnosis code, and resubmit with an ABN if appropriate
Unit calculation errorCARC 151 / 150Resubmit with corrected units and attach the wound measurement and product size documentation
JW or JZ appendedClaim line rejectedRemove the modifier and resubmit, since neither applies to an incident-to supply
Missing prior authorizationCARC 15 / 197Retrospective authorization may be available. Contact the payer within the timely filing window.
Frequency limit exceededCARC 119Appeal with clinical justification for the additional application and cite the policy criteria
Wrong product code billed (for example Q4188 for Artacent Wound)CARC 16 / 236Void and resubmit with the code for the product named on the application note
Conservative care not documentedCARC 50 / 251Appeal with prior visit notes showing moist dressing, compression, or offloading trials

When appealing a CARC 50 or 167 denial, attach the applicable policy to the appeal letter and annotate exactly which criterion your documentation satisfies. A generic letter gives the reviewer no criterion to check your record against.

Verify HCPCS code details through the PGM Billing HCPCS lookup tool and confirm current code status at the CMS HCPCS page before each appeal cycle.

How Pabau supports Q4169 documentation and claims

Most Q4169 denials trace back to the chart. Wound measurements sit in one file, the application note in another, and the biller rebuilds the claim from memory.

Pabau keeps wound measurements and visit notes together on one patient record. Its claims management for practices then submits the claim through Claim.MD and tracks its status.

The outcome is a claim built from the same record an auditor will read. Your team spends less time hunting for notes when a payer asks for them.

Keep wound care records and claims together

Pabau records wound measurements and notes in the patient record and submits claims through Claim.MD. Your billing team works from the same record an auditor reads.

Pabau claims management dashboard

Conclusion

Q4169 is a narrow code: one product, Artacent Wound, billed per square centimeter as an add-on. Most errors come from treating it as a family code for any amniotic graft.

The 2026 changes raise the stakes on accuracy. Medicare now pays one flat rate per square centimeter and nothing for wastage, while MAC policies keep shifting. The record has to show exactly what was applied and why.

Match the code to the product name, bill only what was applied, and recheck your MAC’s policy each January. Book a demo to see how Pabau keeps wound measurements, notes, and claims on one patient record.

Continue your research

Continue your research

Need a denial management framework for wound care codes? Denial codes in medical billing explains common CARC and RARC codes and how to structure an appeal workflow.

Looking to keep wound documentation and claims in one place? Claims management software from Pabau submits claims through Claim.MD and tracks their status from the patient record.

Covering a wound larger than 25 sq cm? CPT 15272 reports each additional 25 sq cm of skin substitute applied to the trunk, arms, or legs.

Frequently asked questions

What is HCPCS Code Q4169?

HCPCS Code Q4169 is the Level II code for Artacent wound, per square centimeter, an add-on reported with the skin substitute application procedure. It covers one product, Artacent Wound, an amniotic membrane skin substitute applied to qualifying chronic wounds such as diabetic foot ulcers and venous leg ulcers.

What is the difference between Q4169 and Q4168?

Q4168 is AmnioBand, billed per 1 mg. Q4169 is Artacent Wound, billed per square centimeter. They are different products with different units, so the product name on the application note decides the code. AmnioArmor bills under Q4188 and Cygnus under Q4170, not under Q4169.

How are units calculated for Q4169?

One unit equals one square centimeter of Artacent Wound, per the code descriptor. Report the square centimeters of product applied, and record the wound measurements that support that size. Discarded product is not payable, and the JW and JZ modifiers do not belong on an incident-to supply.

How much does Medicare pay for Q4169 in 2026?

For 2026, CMS pays non-BLA skin substitutes such as Artacent Wound as incident-to supplies at one flat national rate. A Federal Register correction set that rate at $127.14 per square centimeter, before locality adjustment. Check your MAC fee schedule for the exact amount.

Does Medicare require prior authorization for Q4169?

Traditional Medicare does not require national prior authorization for Q4169, but rules can differ by MAC, so check your MAC’s current policy. Medicare Advantage plans often require prior authorization for skin substitute codes. Confirm the plan’s requirements before scheduling the application.

Avatar photo
Despina Petrushevska
Content Writer

Despina Petrushevska is a content writer covering aesthetics, dermatology, and clinic operations, known for making detailed clinical concepts clear and engaging. Outside of work, she enjoys photography, weekend getaways, and finding inspiration in everyday experiences.
×